Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections

Dr. Anca D. Askanase

Rheumatology
Trustees Of Columbia University In The City Of New York
161 Fort Washington Ave, 
New York, NY 
Offers Telehealth
Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Trustees Of Columbia University In The City Of New York
161 Fort Washington Ave, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Anca Askanase is a Rheumatologist in New York, New York. Dr. Askanase is rated as an Experienced provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. Her top areas of expertise are Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Undifferentiated Connective Tissue Disease (UCTD), and Cutaneous Lupus Erythematosus (CLE).

Her clinical research consists of co-authoring 164 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in NY
Hospital Affiliations
New York-Presbyterian Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VNS Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
161 Fort Washington Ave, New York, NY 10032
Other Locations
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
622 W 168th St, New York, NY 10032

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Open-label Prospective Randomized Study to Determine the Efficacy and Safety of Two Dosing Regimens of ACTHar in the Treatment of Proliferative Lupus Nephritis.
Open-label Prospective Randomized Study to Determine the Efficacy and Safety of Two Dosing Regimens of ACTHar in the Treatment of Proliferative Lupus Nephritis.
Enrollment Status: Terminated
Publish Date: March 07, 2025
Intervention Type: Drug
Study Drugs: CellCept, ACTHar Gel
Study Phase: Phase 4
Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID
Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID
Enrollment Status: Terminated
Publish Date: February 27, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 18, 2022
Intervention Type: Drug
Study Drug: JBT-101
Study Phase: Phase 2
Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis (ITN055AI)
Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis (ITN055AI)
Enrollment Status: Completed
Publish Date: December 01, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 2
View 5 Less Clinical Trials

158 Total Publications

Reply.
Reply.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 24, 2025
Similar Doctors
Distinguished in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Prem C. Chatpar
Rheumatology
Distinguished in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Prem C. Chatpar
Rheumatology
524 Old Country Road, 
Plainview, NY 
 (23.7 miles away)
516-931-3988
Languages Spoken:
English
See accepted insurances

Prem Chatpar is a Rheumatologist in Plainview, New York. Dr. Chatpar is rated as a Distinguished provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. His top areas of expertise are MAGIC Syndrome, Light Chain Deposition Disease (LCDD), Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, and IgG4-Related Disease.

Distinguished in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Ya J. Chang
Rheumatology | Cardiology
Distinguished in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Ya J. Chang
Rheumatology | Cardiology
41 Elizabeth St, Suite 203, 
New York, NY 
 (9.0 miles away)
212-334-9591
Languages Spoken:
English
See accepted insurances

Ya Chang is a Rheumatologist and a Cardiologist in New York, New York. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. His top areas of expertise are Sjogren Syndrome, IgG4-Related Disease, MAGIC Syndrome, and Light Chain Deposition Disease (LCDD).

Advanced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Henghe Tian
Rheumatology
Advanced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Henghe Tian
Rheumatology

Chinatown Medical Consultation PLLC

139 Centre St, 
New York, NY 
 (9.0 miles away)
212-219-2269
Languages Spoken:
English
See accepted insurances

Henghe Tian is a Rheumatologist in New York, New York. Dr. Tian is rated as an Advanced provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. Her top areas of expertise are Light Chain Deposition Disease (LCDD), MAGIC Syndrome, IgG4-Related Disease, and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Askanase's expertise for a condition
ConditionClose
View All 42 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile